Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration
- 22 September 2003
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 18 (6), 1387-1401
- https://doi.org/10.1046/j.1460-9568.2003.02864.x
Abstract
1-Methyl-4-phenylpyridinium (MPP+), the neurotoxic metabolite of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), induces apoptosis in dopaminergic neurons; however, the cellular mechanisms underlying the degenerative process are not well understood. In the present study, we demonstrate that caspase-3 mediated proteolytic activation of protein kinase C delta (PKC delta) is critical in MPP+-induced oxidative stress and apoptosis. MPP+ exposure in rat dopaminergic neuronal cells resulted in time-dependent increases in reactive oxygen species generation, cytochrome c release, and caspase-9 and caspase-3 activation. Interestingly, MPP+ induced proteolytic cleavage of PKC delta (72-74 kDa) into a 41-kDa catalytic and a 38-kDa regulatory subunit, resulting in persistently increased kinase activity. The caspase-3 inhibitor Z-DEVD-fmk effectively blocked MPP+-induced PKC delta cleavage and kinase activity, suggesting that the proteolytic activation is caspase-3 mediated. Similar results were seen in MPP+-treated rat midbrain slices. Z-DEVD-fmk and the PKC delta specific inhibitor rottlerin almost completely blocked MPP+-induced DNA fragmentation. The superoxide dismutase mimetic, MnTBAP also effectively attenuated MPP+-induced caspase-3 activation, PKC delta cleavage, and DNA fragmentation. Furthermore, rottlerin attenuated MPP+-induced caspase-3 activity without affecting basal activity, suggesting positive feedback activation of caspase-3 by PKC delta. Intracellular delivery of catalytically active recombinant PKC delta significantly increased caspase-3 activity, further indicating that PKC delta regulates caspase-3 activity. Finally, over-expression of a kinase inactive PKC delta K376R mutant prevented MPP+-induced caspase activation and DNA fragmentation, confirming the pro-apoptotic function of PKC delta in dopaminergic cell death. Together, we demonstrate for the first time that MPP+-induced oxidative stress proteolytically activates PKC delta in a caspase-3-dependent manner to induce apoptosis and up-regulate the caspase cascade in dopaminergic neuronal cells.Keywords
This publication has 69 references indexed in Scilit:
- The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase CαBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2003
- Role of nuclear PKC ? in mediating caspase-3-upregulation in Jurkat T leukemic cells exposed to ionizing radiationJournal of Cellular Biochemistry, 2002
- Activation of PKC but Not of ERK Is Required for Vitamin E-Succinate-Induced Apoptosis of HL-60 CellsBiochemical and Biophysical Research Communications, 2001
- THE DECREASE OF PKCα IS ASSOCIATED WITH HEPATIC APOPTOSIS AT EARLY AND LATE PHASES OF POLYMICROBIAL SEPSISShock, 2001
- NF-κB Activation in Tumor Necrosis Factor α-stimulated Neutrophils Is Mediated by Protein Kinase CδJournal of Biological Chemistry, 2001
- Cytochrome c-Dependent Activation of Caspase-3 by Tumor Necrosis Factor Requires Induction of the Mitochondrial Permeability TransitionThe American Journal of Pathology, 2000
- Proteolytic Activation of Protein Kinase C δ and ϵ by Caspase-3 in U937 Cells During Chemotherapeutic Agent-Induced ApoptosisCellular Signalling, 1999
- Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Nigral degeneration in parkinson's diseaseMovement Disorders, 1993
- Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase BFEBS Letters, 1985